Back to Menu
The Tumor Radiotherapy Center leverages the hospital's radiotherapy platform and standardized quality control system, equipped with advanced devices including CyberKnife M6, TOMO helical tomography, TrueBeam, Halcyon, and Ethos online adaptive systems. The center covers a wide range of clinical scenarios, from intracranial and extracranial SRS/SBRT to conventional intensity-modulated radiotherapy, providing patients with tumors in different locations, stages, and with recurrent or metastatic disease more comprehensive technical options and treatment plan flexibility. We adhere to the principle of "optimal suitability first," integrating imaging evaluation and dose constraint analysis before treatment, taking into account tumor location, movement characteristics, and proximity to critical organs, to select the most appropriate platform and technical strategy, striving to achieve a controlled balance between target coverage and normal tissue protection.
The center is image-guided and routinely performs pre-treatment positioning verification. For thoracic and abdominal lesions affected by motion, four-dimensional CT is used to evaluate motion range and implement respiratory management. In cases such as left breast tumors requiring heart and lung protection, deep inspiration breath-hold (DIBH) can be applied. For patients with significant anatomical changes during treatment, online imaging evaluation and adaptive planning improve alignment between each irradiation and the patient's anatomy on that day. Dose verification is performed before radiotherapy plan implementation, and all equipment is maintained according to daily, monthly, and yearly inspection protocols to ensure consistency and reproducibility of treatment.
Keeping pace with advancements in medical technology, the center coordinates with surgery, interventional therapy, and systemic treatment, and can also incorporate traditional Chinese medicine and other supportive therapies to form more integrated treatment plans for solid tumors, including liver, lung, nasopharyngeal, breast, and digestive system cancers. During treatment, periodic review and response monitoring are conducted, and subsequent plans are optimized as necessary. Our vision is to transform advanced equipment and meticulous quality control into actionable, reviewable clinical services, providing patients with more precise irradiation, controllable side effects, and a continuous, one-stop treatment experience.
